Skip to content
You need to accept statistical cookies to view the video. Click here.
Learn how researchers and clinicians are utilizing a novel approach using bispecifics or dual-targeting antibodies with the goal to bring new treatment options for cancer patients.
Putting our expertise to work
See how we put our in-depth knowledge of antibody biology into action
Learn about our science
Innovation for the future
Leveraging technologies to create first- or best-in-class products
See our technologies
This site is for U.S. residents only.
You are now leaving the current website and will be directed to additional information. Click "Continue" to confirm that you are a U.S. resident.
You are now leaving Genmab.com and will be directed to a page intended for U.S. audiences only. Click Continue to confirm you are located in the U.S.